204 related articles for article (PubMed ID: 28529305)
1. Folic Acid-Targeted Etoposide Cubosomes for Theranostic Application of Cancer Cell Imaging and Therapy.
Tian Y; Li JC; Zhu JX; Zhu N; Zhang HM; Liang L; Sun L
Med Sci Monit; 2017 May; 23():2426-2435. PubMed ID: 28529305
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system.
Zhang S; Lu C; Zhang X; Li J; Jiang H
Drug Deliv; 2016 Jun; 23(5):1838-45. PubMed ID: 26879035
[TBL] [Abstract][Full Text] [Related]
3. Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer's disease: pharmaceutical, biological, and toxicological studies.
Elnaggar YS; Etman SM; Abdelmonsif DA; Abdallah OY
Int J Nanomedicine; 2015; 10():5459-73. PubMed ID: 26346130
[TBL] [Abstract][Full Text] [Related]
4. A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: Preparation, cytotoxicity and intracellular uptake.
Luo Q; Lin T; Zhang CY; Zhu T; Wang L; Ji Z; Jia B; Ge T; Peng D; Chen W
Int J Pharm; 2015 Sep; 493(1-2):30-9. PubMed ID: 26209071
[TBL] [Abstract][Full Text] [Related]
5. Transcription activator, hyaluronic acid and tocopheryl succinate multi-functionalized novel lipid carriers encapsulating etoposide for lymphoma therapy.
Wang H; Sun G; Zhang Z; Ou Y
Biomed Pharmacother; 2017 Jul; 91():241-250. PubMed ID: 28460227
[TBL] [Abstract][Full Text] [Related]
6. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
7. Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes.
Guo F; Yu M; Wang J; Tan F; Li N
ACS Appl Mater Interfaces; 2015 Sep; 7(37):20556-67. PubMed ID: 26322900
[TBL] [Abstract][Full Text] [Related]
8. Folic acid conjugated guar gum nanoparticles for targeting methotrexate to colon cancer.
Sharma M; Malik R; Verma A; Dwivedi P; Banoth GS; Pandey N; Sarkar J; Mishra PR; Dwivedi AK
J Biomed Nanotechnol; 2013 Jan; 9(1):96-106. PubMed ID: 23627072
[TBL] [Abstract][Full Text] [Related]
9. Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.
Zarrin A; Sadighian S; Rostamizadeh K; Firuzi O; Hamidi M; Mohammadi-Samani S; Miri R
Int J Pharm; 2016 Mar; 500(1-2):62-76. PubMed ID: 26721723
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies on glycerol monooleate- and phytantriol-based cubosomes containing oridonin in vitro and in vivo.
Shi X; Peng T; Huang Y; Mei L; Gu Y; Huang J; Han K; Li G; Hu C; Pan X; Wu C
Pharm Dev Technol; 2017 May; 22(3):322-329. PubMed ID: 26670780
[TBL] [Abstract][Full Text] [Related]
11. Folate receptor-targeted theranostic IrS
Zhang DY; Zheng Y; Zhang H; Yang GG; Tan CP; He L; Ji LN; Mao ZW
Nanoscale; 2018 Dec; 10(47):22252-22262. PubMed ID: 30465053
[TBL] [Abstract][Full Text] [Related]
12. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
[TBL] [Abstract][Full Text] [Related]
13. Development of a folate-modified curcumin loaded micelle delivery system for cancer targeting.
Yang C; Chen H; Zhao J; Pang X; Xi Y; Zhai G
Colloids Surf B Biointerfaces; 2014 Sep; 121():206-13. PubMed ID: 24984268
[TBL] [Abstract][Full Text] [Related]
14. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
[TBL] [Abstract][Full Text] [Related]
15. Cancer-cell-targeted theranostic cubosomes.
Caltagirone C; Falchi AM; Lampis S; Lippolis V; Meli V; Monduzzi M; Prodi L; Schmidt J; Sgarzi M; Talmon Y; Bizzarri R; Murgia S
Langmuir; 2014 Jun; 30(21):6228-36. PubMed ID: 24815031
[TBL] [Abstract][Full Text] [Related]
16. Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with p-aminophenyl-α-D-manno-pyranoside and folic acid.
Kuo YC; Lee CH
J Pharm Sci; 2015 May; 104(5):1804-14. PubMed ID: 25694089
[TBL] [Abstract][Full Text] [Related]
17. A novel small Odorranalectin-bearing cubosomes: preparation, brain delivery and pharmacodynamic study on amyloid-β₂₅₋₃₅-treated rats following intranasal administration.
Wu H; Li J; Zhang Q; Yan X; Guo L; Gao X; Qiu M; Jiang X; Lai R; Chen H
Eur J Pharm Biopharm; 2012 Feb; 80(2):368-78. PubMed ID: 22061263
[TBL] [Abstract][Full Text] [Related]
18. Novel dual targeting cubosomes modified with angiopep-2 for co-delivery GNA and PLHSpT to brain glioma.
Lin T; Wei Q; Zhang H; Yang Y; Jiang B; Wang Z; Li S; Wang Q; Hu M; Chen W; Wang L; Ding B
J Biomater Appl; 2024 Jan; 38(6):743-757. PubMed ID: 38000075
[TBL] [Abstract][Full Text] [Related]
19. DNA biodots based targeted theranostic nanomedicine for the imaging and treatment of non-small cell lung cancer.
Jha A; Viswanadh MK; Burande AS; Mehata AK; Poddar S; Yadav K; Mahto SK; Parmar AS; Muthu MS
Int J Biol Macromol; 2020 May; 150():413-425. PubMed ID: 32057849
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy.
Kılıçay E; Demirbilek M; Türk M; Güven E; Hazer B; Denkbas EB
Eur J Pharm Sci; 2011 Oct; 44(3):310-20. PubMed ID: 21884788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
